Get the Relief You
Deserve from Your Pain Medication
Your DNA can help you find a better medication.
“I cannot put into words how valuable this is to me"
Our Pain & Mental Health test will provide you with life-long insights to help you and your health care provider limit trial and error, avoid side effects, and improve your outcomes sooner.
-
Avoid Trial & Error
Science has evolved, and we now know that your genetic makeup is a guide to how your body responds to medications. Relying on a one-size-fits-all approach can lead to unnecessary trial and error.
-
Reduce Side Effects
Understanding genetic responses to medication can reduce the risk of side effects by 30%. †
-
100% Tailored to You
76% of those who took Inagene's pharmacogenetics test had a change made to their treatment plan as a result of the insights provided. ‡
100% backed by science
We combine the world’s best science with insights from your DNA to provide personalized recommendations you can trust.
How It Works
It starts with a simple cheek swab test at home
-
Swab your cheek with our kit and mail it to our lab with the package provided.
-
When your results are ready, view and download your personalized insights report.
-
Discuss your results with your healthcare provider to optimize your treatment plan.
The Inagene report
Your Inagene report is a personalized guide on how your genetic information affects your body’s needs. It delivers clear recommendations so you can make informed personal health decisions, avoid trial and error, prevent side effects, and find effective medications faster. The report places medications into four categories, based on the detection of specific genetic variants known to impact individual responses to drugs:
-
Consider Alternatives
Genetic variant(s) potentially impacting response to this medication were identified. This medication may not be appropriate. Consult the “detailed recommendations” section of the report for details.
-
Consider Modified Approach
Genetic variant(s) potentially impacting response to this medication were identified. Consult the “detailed recommendations” section of the report for details.
-
Use Standard Precautions
No genetic variants impacting response to this medication were identified.
-
Use Standard Precautions (Preferred)
Genetic variant(s) potentially improving response to this medication were identified. Consult the “detailed recommendations” section of the report for details.
Your privacy is our top priority
-
Secure Data Handling
-
Strict Confidentiality
-
Accredited Laboratory
-
Transparent Practices
FAQ
Which diseases/conditions does the test cover?
Your Inagene Report doesn’t provide disease risk information, but rather describes your unique predicted response to medications commonly used to treat a variety of pain and mental health conditions, and other conditions (eg. Anesthesia, Cardiology, Endocrinology, Gastroenterology, Immunology, Infectious Disease, Neurology, Oncology, Respirology and Urology). The results are specific to individual medications (not health conditions), so the recommendations apply regardless of what type of pain, mental health, or other health conditions the drug is being used to treat.
What can Inagene reveal about my treatment strategy?
Your Inagene report offers guidance on which drugs are likely to work best for you, and which you should avoid – based on increased risk of side effects or drug interactions – so you and your healthcare team can manage your health concerns as effectively and safely as possible. The reports are available on our secure portal so that you can easily share your reports with others.
Where do the recommendations in the report come from?
The recommendations in Inagene’s report are backed by published, publicly available pharmacogenetic recommendations from several well-recognized, government-funded governing bodies that have been established over the past two decades in the USA, Europe, and Asia. We pair this science and expertise with the insights gleaned from your DNA profile to provide you with personalized insights you can trust.
-
References
-
† Swen JJ, van der Wouden CH, Manson LE, et al.
‡ Inagene Patient Pilot Study; 2021